3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Osteosarcoma
2
Renal Insufficiency
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Lymphoma
1
Leukemia
1
Hematologic Neoplasms
1
Interventions
Dexamethasone
2
Azacitidine
2
sacubitril and valsartan sodium hydrate drug combination
1
regorafenib
1
pevonedistat
1
melflufen
1
glucarpidase
1
gamma-Glutamyl Hydrolase
1
copanlisib
1
carfilzomib
1
Thalidomide
1
Methotrexate
1
Leucovorin
1
L-melphalanyl-p-L-fluorophenylalanine ethyl ester
1
Cyclophosphamide
1
Bortezomib
1
Bendamustine Hydrochloride
1
ARQ 197
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Renal Insufficiency
×
glucarpidase
×
Clear all
NCT00634504
2022-06-06
LVPK
BTG International Inc.
Phase 1
Completed
20 enrolled
9 charts